Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
4626
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.77M | ﹤0.01% |
29,600
-16,900
| -36% | -$904K |
|
|
PRA
4627
DELISTED
ProAssurance
PRA
| $1.77M | ﹤0.01% |
122,104
-19,585
| -14% | -$336K |
|
4628
PUT
Aecom
ACM
$8.12B
| $1.77M | ﹤0.01% |
47,000
-95,800
| -67% | -$3.43M |
|
4629
OrthoPediatrics
KIDS
$648M
| $1.77M | ﹤0.01% |
40,365
+15,710
| +64% | +$707K |
|
4630
PUT
American Eagle Outfitters
AEO
$2.71B
| $1.76M | ﹤0.01% |
161,900
-59,600
| -27% | -$564K |
|
4631
PUT
Louisiana-Pacific
LPX
$5.17B
| $1.76M | ﹤0.01% |
68,700
+32,400
| +89% | +$686K |
|
4632
CALL
RenaissanceRe
RNR
$13.4B
| $1.76M | ﹤0.01% |
10,300
-1,400
| -12% | -$230K |
|
4633
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $1.76M | ﹤0.01% |
29,000
-143,978
| -83% | -$8.27M |
|
4634
CALL
Upwork
UPWK
$1.06B
| $1.76M | ﹤0.01% |
121,600
+66,600
| +121% | +$699K |
|
4635
CALL
Ares Management
ARES
$32.5B
| $1.75M | ﹤0.01% |
44,200
+34,000
| +333% | +$1.2M |
|
4636
MGP Ingredients
MGPI
$379M
| $1.75M | ﹤0.01% |
47,803
+5,429
| +13% | +$194K |
|
4637
PUT
Paylocity
PCTY
$7.87B
| $1.75M | ﹤0.01% |
12,000
-3,600
| -23% | -$419K |
|
4638
Columbia Sportswear
COLM
$2.94B
| $1.75M | ﹤0.01% |
+21,703
| New | +$1.58M |
|
|
PETQ
4639
CALL
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.75M | ﹤0.01% |
50,200
-27,300
| -35% | -$766K |
|
4640
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$740M
| $1.75M | ﹤0.01% |
20,964
+12,913
| +160% | +$1.07M |
|
|
LTC
4641
CALL
LTC Properties
LTC
$2.17B
| $1.74M | ﹤0.01% |
46,300
+31,700
| +217% | +$1.13M |
|
4642
James Hardie Industries
JHX
$18B
| $1.74M | ﹤0.01% |
90,620
+53,929
| +147% | +$828K |
|
4643
PUT
The RealReal
REAL
$1.39B
| $1.74M | ﹤0.01% |
136,100
-20,400
| -13% | -$243K |
|
4644
CALL
Sibanye-Stillwater
SBSW
$7.62B
| $1.74M | ﹤0.01% |
201,300
+23,000
| +13% | +$175K |
|
4645
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $1.74M | ﹤0.01% |
23,400
+13,114
| +127% | +$838K |
|
|
AGNT
4646
AGNT Inc
AGNT
$727M
| $1.74M | ﹤0.01% |
204,144
+61,988
| +44% | +$318K |
|
|
APLS
4647
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $1.74M | ﹤0.01% |
53,200
-70,900
| -57% | -$2.28M |
|
4648
PUT
Pricesmart
PSMT
$5.56B
| $1.74M | ﹤0.01% |
28,800
+15,800
| +122% | +$911K |
|
4649
Carriage Services
CSV
$579M
| $1.74M | ﹤0.01% |
95,793
-17,812
| -16% | -$300K |
|
4650
CALL
Icon
ICLR
$12.6B
| $1.74M | ﹤0.01% |
10,300
-300
| -3% | -$47.3K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.